SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-23-001389
Filing Date
2023-08-07
Accepted
2023-08-07 11:35:38
Documents
15
Period of Report
2023-08-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4907_8k.htm   iXBRL 8-K 26216
2 EXHIBIT 3.1 e4907_ex3-1.htm EX-3.1 1609
3 GRAPHIC img_001.jpg GRAPHIC 1829100
4 GRAPHIC img_002.jpg GRAPHIC 2361008
  Complete submission text file 0001731122-23-001389.txt   5957179

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE enob-20230801.xsd EX-101.SCH 3024
6 XBRL LABEL FILE enob-20230801_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE enob-20230801_pre.xml EX-101.PRE 22365
9 EXTRACTED XBRL INSTANCE DOCUMENT e4907_8k_htm.xml XML 3428
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 231146267
SIC: 2834 Pharmaceutical Preparations